Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5P4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,545
Award facts
- Contract value 100% obligated
- $10,544.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,544.66 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 22, 2026, for the supply of Myrbetriq ER 50 mg tablets (90-count packages). This is a firm fixed-price delivery order with no set-aside designation, executed under full and open competition. The contract is scheduled for ultimate completion on January 23, 2026, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of prescription medications, generic drugs, vaccines, and medical supplies to support military healthcare programs globally. The DLA Medical Supply Chain utilizes such contracts to efficiently deliver essential pharmaceutical products to military treatment facilities, veterans' healthcare systems, and other federal medical institutions, with AmerisourceBergen demonstrating consistent capability to fulfill diverse federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJ5P4?
SPE2DR26FJ5P4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FJ5P4 worth?
The government has obligated $10,545 on SPE2DR26FJ5P4.
Is contract SPE2DR26FJ5P4 an order under another contract?
Yes. SPE2DR26FJ5P4 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5P4 competed?
The extent of competition for SPE2DR26FJ5P4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award